ATE346921T1 - Menschliches, durch kalzium aktivierbares kaliumkanalpolypeptid aus leukozyten - Google Patents

Menschliches, durch kalzium aktivierbares kaliumkanalpolypeptid aus leukozyten

Info

Publication number
ATE346921T1
ATE346921T1 AT98933785T AT98933785T ATE346921T1 AT E346921 T1 ATE346921 T1 AT E346921T1 AT 98933785 T AT98933785 T AT 98933785T AT 98933785 T AT98933785 T AT 98933785T AT E346921 T1 ATE346921 T1 AT E346921T1
Authority
AT
Austria
Prior art keywords
potassium channel
calcium
channel polypeptide
activated
activated potassium
Prior art date
Application number
AT98933785T
Other languages
English (en)
Inventor
Jayashree Aiyar
Naomi Jean Logsdon
Original Assignee
Astrazeneca Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9714760.7A external-priority patent/GB9714760D0/en
Priority claimed from GBGB9721366.4A external-priority patent/GB9721366D0/en
Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd
Application granted granted Critical
Publication of ATE346921T1 publication Critical patent/ATE346921T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98933785T 1997-07-15 1998-07-13 Menschliches, durch kalzium aktivierbares kaliumkanalpolypeptid aus leukozyten ATE346921T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9714760.7A GB9714760D0 (en) 1997-07-15 1997-07-15 Method
GBGB9721366.4A GB9721366D0 (en) 1997-10-09 1997-10-09 Human lymph node derived calcium activated potassium channel

Publications (1)

Publication Number Publication Date
ATE346921T1 true ATE346921T1 (de) 2006-12-15

Family

ID=26311877

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98933785T ATE346921T1 (de) 1997-07-15 1998-07-13 Menschliches, durch kalzium aktivierbares kaliumkanalpolypeptid aus leukozyten

Country Status (7)

Country Link
EP (1) EP1012281B1 (de)
JP (1) JP2001520524A (de)
AT (1) ATE346921T1 (de)
AU (1) AU8348498A (de)
DE (1) DE69836546T2 (de)
ES (1) ES2276466T3 (de)
WO (1) WO1999003882A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0948542B1 (de) 1996-09-11 2007-07-04 Oregon Health Sciences University Kalzium-aktivierte kaliumkanäle mit niedriger und mittlerer leitfähigkeit und ihre verwendungen.
WO2001094390A2 (en) * 2000-06-06 2001-12-13 Millennium Pharmaceuticals, Inc. 52906, 33408, and 12189, potassium channel family members and uses thereof
GB0021487D0 (en) * 2000-09-01 2000-10-18 Pfizer Ltd Pharmaceutical
CA2742610A1 (en) * 2008-11-10 2010-05-14 Jun Li Compositions and methods for modulating cell-cell fusion via intermediate-conductance calcium-activated potassium channels

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0948542B1 (de) * 1996-09-11 2007-07-04 Oregon Health Sciences University Kalzium-aktivierte kaliumkanäle mit niedriger und mittlerer leitfähigkeit und ihre verwendungen.

Also Published As

Publication number Publication date
JP2001520524A (ja) 2001-10-30
AU8348498A (en) 1999-02-10
WO1999003882A2 (en) 1999-01-28
WO1999003882A3 (en) 1999-04-08
DE69836546D1 (de) 2007-01-11
ES2276466T3 (es) 2007-06-16
DE69836546T2 (de) 2007-09-27
EP1012281A2 (de) 2000-06-28
EP1012281B1 (de) 2006-11-29

Similar Documents

Publication Publication Date Title
PT93910A (pt) Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
EA199700359A1 (ru) Пептиды и соединения, связывающиеся с тромбопоэтиновым рецептором
DE69836088D1 (de) Als lerk6 bezeichnetes cytokin
DE602004023725D1 (de) Muteine von tränen-lipocalin
ES2108759T3 (es) Utilizacion de la piel no pigmentada de pescado, en particular de pescado plano como nueva fuente industrial de colageno, procedimiento de extraccion, colageno y biomaterial asi obtenidos.
IL106248A (en) Adhesive compositions and method of bonding biological tissue to a substance
SE8204382D0 (sv) Process for producing target cell lysis factor and uses therewith
DK0479948T3 (da) Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
ATE484587T1 (de) Ldcam genannte moleküle
BRPI0314666B8 (pt) composição nutricional ou terapêutica utilizável para o tratamento de mamíferos para aumentar a atividade imune
ES2138973T3 (es) Muteinas de il-6 exentas de cisteina.
DE69632828D1 (de) Peptide des antisekretorischen faktors, welches krankhafte permeabilitätsanderungen reguliert
ATE346921T1 (de) Menschliches, durch kalzium aktivierbares kaliumkanalpolypeptid aus leukozyten
DE60235985D1 (de) Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk)
FI971276A (fi) Lerk-6:ksi nimetty sytokiini
SE9602822D0 (sv) New receptor
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
CY1109904T1 (el) Προαγωγεας της il-18bp, η παρασκευη και χρηση του
ATE309359T1 (de) Epil/plazentin
EP0351591A3 (de) 2-tert.-Butyl-4-chlor-5-(4-tert.-butylbenzylthio)-3-(2H) -pyridazinon zur Bekämpfung von Schnecken
HK1031664A1 (en) Use of an organ-specific nutritional composition
ES2097368T3 (es) Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas terrestres.
DE10080849D2 (de) Fragmente des Virus Proteins 2 oder 3 des Polymavirus als Fähren für Wirkstoffe
DE69812597D1 (de) Peptide zur Inhibition von HPV E7 Proteinen
EA200000709A1 (ru) Бета-липотропин и его применения

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties